Advertisement

Association of Histocompatibility Antigen Expression with Intracerebral Tumorigenicity

  • Toshiki Yamasaki
  • Kouzo Moritake
  • Seiichi Nagao
  • Yasuhiko Akiyama
  • Masako Kawahara

Abstract

Although the major histocompatibility complex (MHC, H-2 in mouse) class I and class II antigens are either absent or are present only at low levels in the brain, it has been recognized that various kinds of immune reactions may take place within the brain [1–4]. With regard to the immunology of H-2 class I antigen expression, it has been reported that there is a relationship between the level of cell surface H-2 expression and cytotoxic T lymphocyte (CTL) or natural killer cell (NK) susceptibility in certain tumor systems [5]. In the central nervous system, however, little is known about natural resistance mediated by the cytotoxic cellular interaction between T cells and NK cells. Thus, in the present study, we have focused upon examining the immuno-surveillance mechanism for tumor rejection selectively acting in association with MHC class I antigen expression, using a mouse lymphoma system.

Keywords

Natural Killer Natural Killer Cell Syngeneic Mouse Intracerebral Inoculation Thymectomized Mouse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lampson LA (1987) Molecular bases of the immune response to neural antigens. Trends Neurosci 10: 211–216CrossRefGoogle Scholar
  2. 2.
    Schnitzer J, Schachner M (1981) Expression of Thy-1, H-2 and NS-4 cell surface antigens and tetanus toxin receptors in early postnatal and adult mouse cerebellum. J Neuroimmunol 1: 429–456PubMedCrossRefGoogle Scholar
  3. 3.
    Morantz RA, Shain W, Cravioto H (1978) Immune surveillance and tumors of the nervous system. J Neurosurg 49: 84–92PubMedCrossRefGoogle Scholar
  4. 4.
    Yamasaki T, Handa H, Yamashita J, et al. (1983) Characteristic immunological responses to an experimental mouse brain tumor. Cancer Res 43: 4610–4617PubMedGoogle Scholar
  5. 5.
    Kärre K, Ljunggren HG, Piontek G, et al. (1986) Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy. Nature 319: 675–678PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1991

Authors and Affiliations

  • Toshiki Yamasaki
  • Kouzo Moritake
  • Seiichi Nagao
  • Yasuhiko Akiyama
  • Masako Kawahara
    • 1
  1. 1.Department of NeurosurgeryShimane Medical UniversityIzumo, 693Japan

Personalised recommendations